Historically, innovation in the pharmaceutical industry has centered around the discovery of active pharmaceutical ingredients. A new, potentially life-saving treatment, however, can only make a difference if physicians can access a reliable supply.
With strong legislative and corporate commitment, we can foster innovation around advanced recycling to make a more circular future for the materials industry. But “reduce, reuse, recycle” is only the beginning.
The European Union is well on its way to implementing a series of pivotal environmental regulations that cover everything from water quality to carbon emissions and biodiversity preservation.
To achieve true material circularity, we need material-to-material molecular recycling. To create a circular economy, we need to invest in better access, collection and sorting within the mechanical recycling system.
Global hygiene and health company Essity has, for the fifth consecutive year, been recognized for its leadership in sustainability by the global non-profit environmental organization CDP.
The latest report from the research technology company Glow, in collaboration with 3BL, TriplePundit and panel partner Cint, The $44 Billion Sustainability Opportunity for Brands is stirring up attention and sparking conversation.
